Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aneliya Velkova

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|April 19, 2012
CHEKing out of mitosisAneliya Velkova, Alvaro N A Monteiro
Nature Medicine|October 13, 2011
Epigenetic tumor suppression by BRCA1Aneliya Velkova, Alvaro N A Monteiro
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|November 13, 2008
Comparison of the global genomic and transcription-coupled repair rates of different lesions in human cellsBoyko Atanassov, Aneliya Velkova, Emil Mladenov, et al.
Cancer Biology & Therapy|March 23, 2006
DNA damage response: determining the fate of phosphorylated histone H2AXJonathan Rios-Doria, Alyson Fay, Aneliya Velkova, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 13, 2009
Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?J Thomas De Ligio, Aneliya Velkova, Diego A R Zorio, et al.
Cell Cycle (Georgetown, Tex.)|March 23, 2010
Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repairAneliya Velkova, Marcelo A Carvalho, Joseph O Johnson, et al.
European Journal of Clinical Investigation|March 9, 2016
Association of a transcobalamin II genetic variant with falsely low results for the holotranscobalamin immunoassayAgata Sobczyńska-Malefora, Faith Pangilinan, Gordon T Plant, et al.
Cancer Biology & Therapy|March 24, 2009
Ectopic expression of histone H2AX mutants reveals a role for its post-translational modificationsJonathan Rios-Doria, Aneliya Velkova, Virna Dapic, et al.
Plos One|May 22, 2014
Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1Renato S Carvalho, Renata B V Abreu, Aneliya Velkova, et al.
Human Molecular Genetics|October 18, 2017
The FUT2 secretor variant p.Trp154Ter influences serum vitamin B12 concentration via holo-haptocorrin, but not holo-transcobalamin, and is associated with haptocorrin glycosylationAneliya Velkova, Jennifer E L Diaz, Faith Pangilinan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|April 19, 2012
CHEKing out of mitosisAneliya Velkova, Alvaro N A Monteiro
Nature Medicine|October 13, 2011
Epigenetic tumor suppression by BRCA1Aneliya Velkova, Alvaro N A Monteiro
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|November 13, 2008
Comparison of the global genomic and transcription-coupled repair rates of different lesions in human cellsBoyko Atanassov, Aneliya Velkova, Emil Mladenov, et al.
Cancer Biology & Therapy|March 23, 2006
DNA damage response: determining the fate of phosphorylated histone H2AXJonathan Rios-Doria, Alyson Fay, Aneliya Velkova, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 13, 2009
Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?J Thomas De Ligio, Aneliya Velkova, Diego A R Zorio, et al.
Cell Cycle (Georgetown, Tex.)|March 23, 2010
Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repairAneliya Velkova, Marcelo A Carvalho, Joseph O Johnson, et al.
European Journal of Clinical Investigation|March 9, 2016
Association of a transcobalamin II genetic variant with falsely low results for the holotranscobalamin immunoassayAgata Sobczyńska-Malefora, Faith Pangilinan, Gordon T Plant, et al.
Cancer Biology & Therapy|March 24, 2009
Ectopic expression of histone H2AX mutants reveals a role for its post-translational modificationsJonathan Rios-Doria, Aneliya Velkova, Virna Dapic, et al.
Plos One|May 22, 2014
Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1Renato S Carvalho, Renata B V Abreu, Aneliya Velkova, et al.
Human Molecular Genetics|October 18, 2017
The FUT2 secretor variant p.Trp154Ter influences serum vitamin B12 concentration via holo-haptocorrin, but not holo-transcobalamin, and is associated with haptocorrin glycosylationAneliya Velkova, Jennifer E L Diaz, Faith Pangilinan, et al.
Pageof 2